Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Lyra Therapeutics Inc’s stock clocked out at $0.10, down -9.82% from its previous closing price of $0.11. In other words, the price has decreased by -$9.82 from its previous closing price. On the day, 3.02 million shares were traded. LYRA stock price reached its highest trading level at $0.1021 during the session, while it also had its lowest trading level at $0.094.
Ratios:
To gain a deeper understanding of LYRA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.96 and its Current Ratio is at 2.96. In the meantime, Its Debt-to-Equity ratio is 8.62 whereas as Long-Term Debt/Eq ratio is at 7.52.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on May 07, 2024, Downgraded its rating to Hold and sets its target price to $0.50 from $10 previously.
On May 07, 2024, H.C. Wainwright Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $12 to $2.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 25 ’25 when Waksal Harlan bought 145,370 shares for $0.10 per share.
Palasis Maria bought 39,567 shares of LYRA for $3,545 on Apr 09 ’25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LYRA now has a Market Capitalization of 6388158 and an Enterprise Value of 8009160. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.37 while its Price-to-Book (P/B) ratio in mrq is 1.64. Its current Enterprise Value per Revenue stands at 6.759 whereas that against EBITDA is -0.179.
Stock Price History:
The Beta on a monthly basis for LYRA is 0.01, which has changed by -0.71929824 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, LYRA has reached a high of $0.40, while it has fallen to a 52-week low of $0.08. The 50-Day Moving Average of the stock is -20.05%, while the 200-Day Moving Average is calculated to be -52.85%.
Shares Statistics:
It appears that LYRA traded 3.23M shares on average per day over the past three months and 12834540 shares per day over the past ten days. A total of 65.88M shares are outstanding, with a floating share count of 55.76M. Insiders hold about 15.85% of the company’s shares, while institutions hold 36.55% stake in the company. Shares short for LYRA as of 1745971200 were 2702380 with a Short Ratio of 0.84, compared to 1743379200 on 2412416. Therefore, it implies a Short% of Shares Outstanding of 2702380 and a Short% of Float of 5.140000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
